These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

209 related items for PubMed ID: 34547182

  • 1. Impact of allogeneic stem cell transplantation comorbidity indexes after haplotransplant using post-transplant cyclophosphamide.
    Jullien M, Orvain C, Berceanu A, Couturier MA, Guillaume T, Peterlin P, Garnier A, Le Bourgeois A, Klemencie M, Schmidt A, Hunault M, Daguindau E, Roussel X, Delepine P, Guillerm G, Giltat A, François S, Thepot S, Le Gouill S, Béné MC, Chevallier P.
    Cancer Med; 2021 Oct; 10(20):7194-7202. PubMed ID: 34547182
    [Abstract] [Full Text] [Related]

  • 2. Who Is a Better Donor for Recipients of Allogeneic Hematopoietic Cell Transplantation: A Young HLA-Mismatched Haploidentical Relative or an Older Fully HLA-Matched Sibling or Unrelated Donor?
    Karam E, Laporte J, Solomon SR, Morris LE, Zhang X, Holland HK, Bashey A, Solh MM.
    Biol Blood Marrow Transplant; 2019 Oct; 25(10):2054-2060. PubMed ID: 31173900
    [Abstract] [Full Text] [Related]

  • 3. Early Post-Transplantation Serum Ferritin Level Predicts Survival in Recipients of Haploidentical Stem Cell Transplantation Using Post-Transplantation Cyclophosphamide as Graft-versus-Host Disease Prophylaxis.
    Jullien M, Orvain C, Berceanu A, Couturier MA, Guillaume T, Peterlin P, Garnier A, Bourgeois AL, Klemencie M, Schmidt A, Hunault M, Daguindau E, Roussel X, Delepine P, Guillerm G, Giltat A, François S, Thepot S, Gouill SL, Béné MC, Chevallier P.
    Transplant Cell Ther; 2021 Oct; 27(10):861.e1-861.e7. PubMed ID: 34245928
    [Abstract] [Full Text] [Related]

  • 4. Comparison of two pretransplant predictive models and a flexible HCT-CI using different cut off points to determine low-, intermediate-, and high-risk groups: the flexible HCT-CI Is the best predictor of NRM and OS in a population of patients undergoing allo-RIC.
    Barba P, Piñana JL, Martino R, Valcárcel D, Amorós A, Sureda A, Briones J, Delgado J, Brunet S, Sierra J.
    Biol Blood Marrow Transplant; 2010 Mar; 16(3):413-20. PubMed ID: 19922807
    [Abstract] [Full Text] [Related]

  • 5. Post-transplantation Cyclophosphamide and Sirolimus after Haploidentical Hematopoietic Stem Cell Transplantation Using a Treosulfan-based Myeloablative Conditioning and Peripheral Blood Stem Cells.
    Cieri N, Greco R, Crucitti L, Morelli M, Giglio F, Levati G, Assanelli A, Carrabba MG, Bellio L, Milani R, Lorentino F, Stanghellini MT, De Freitas T, Marktel S, Bernardi M, Corti C, Vago L, Bonini C, Ciceri F, Peccatori J.
    Biol Blood Marrow Transplant; 2015 Aug; 21(8):1506-14. PubMed ID: 26001696
    [Abstract] [Full Text] [Related]

  • 6. The Dilemma of Conditioning Intensity: When Does Myeloablative Conditioning Improve Outcomes for Allogeneic Hematopoietic Cell Transplantation.
    Solh MM, Solomon SR, Morris LE, Zhang X, Holland HK, Bashey A.
    Biol Blood Marrow Transplant; 2019 Mar; 25(3):606-612. PubMed ID: 30244109
    [Abstract] [Full Text] [Related]

  • 7. Outcome of haploidentical versus matched sibling donors in hematopoietic stem cell transplantation for adult patients with acute lymphoblastic leukemia: a study from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation.
    Nagler A, Labopin M, Houhou M, Aljurf M, Mousavi A, Hamladji RM, Al Zahrani M, Bondarenko S, Arat M, Angelucci E, Koc Y, Gülbas Z, Sica S, Bourhis JH, Canaani J, Brissot E, Giebel S, Mohty M.
    J Hematol Oncol; 2021 Apr 01; 14(1):53. PubMed ID: 33794963
    [Abstract] [Full Text] [Related]

  • 8. Haploidentical hematopoietic stem cell transplantation without in vitro T cell depletion for the treatment of philadelphia chromosome-positive acute lymphoblastic leukemia.
    Chen H, Liu KY, Xu LP, Chen YH, Han W, Zhang XH, Wang Y, Qin YZ, Liu YR, Huang XJ.
    Biol Blood Marrow Transplant; 2015 Jun 01; 21(6):1110-6. PubMed ID: 25698612
    [Abstract] [Full Text] [Related]

  • 9. A Comparison of the Myeloablative Conditioning Regimen Fludarabine/Busulfan with Cyclophosphamide/Total Body Irradiation, for Allogeneic Stem Cell Transplantation in the Modern Era: A Cohort Analysis.
    Gooptu M, Kim HT, Ho VT, Alyea EP, Koreth J, Armand P, Ritz J, Nikiforow S, Glotzbecker BE, Nageshwar P, Soiffer RJ, Antin JH, Cutler CS.
    Biol Blood Marrow Transplant; 2018 Aug 01; 24(8):1733-1740. PubMed ID: 29555313
    [Abstract] [Full Text] [Related]

  • 10. Haploidentical Hematopoietic Cell Transplant with Post-Transplant Cyclophosphamide and Peripheral Blood Stem Cell Grafts in Older Adults with Acute Myeloid Leukemia or Myelodysplastic Syndrome.
    Slade M, DiPersio JF, Westervelt P, Vij R, Schroeder MA, Romee R.
    Biol Blood Marrow Transplant; 2017 Oct 01; 23(10):1736-1743. PubMed ID: 28688919
    [Abstract] [Full Text] [Related]

  • 11. Bone marrow versus peripheral blood as a graft source for haploidentical donor transplantation in adults using post-transplant cyclophosphamide-A systematic review and meta-analysis.
    Yu X, Liu L, Xie Z, Dong C, Zhao L, Zhang J, Gu J, Zhu HH.
    Crit Rev Oncol Hematol; 2019 Jan 01; 133():120-128. PubMed ID: 30661648
    [Abstract] [Full Text] [Related]

  • 12. [Prognostic implications of hematopoietic cell transplantation-specific comorbidity index on non-relapse mortality and overall survival after allogeneic hematopoietic stem cell transplantation].
    Wang CY, Ren HY, Qiu ZX, Wang Y, Cen XN, Wang LH, Wang MJ, Xu WL, Wang WS, Li Y, Dong YJ, Ou JP, Liang ZY, Liu W, Wang Q.
    Zhonghua Xue Ye Xue Za Zhi; 2013 Aug 01; 34(8):659-63. PubMed ID: 23978015
    [Abstract] [Full Text] [Related]

  • 13. Validation of the Revised Pretransplant Assessment of Mortality Score in Patients with Acute Myelogenous Leukemia Undergoing Allogeneic Hematopoietic Stem Cell Transplantation.
    Middeke JM, Kollinger F, Baldauf H, Stölzel F, Wermke M, von Bonin M, Sockel K, Link CS, Teipel R, Röllig C, Thiede C, Platzbecker U, Ehninger G, Bornhäuser M, Schetelig J.
    Biol Blood Marrow Transplant; 2018 Sep 01; 24(9):1947-1951. PubMed ID: 29793046
    [Abstract] [Full Text] [Related]

  • 14. The hematopoietic cell transplantation-specific comorbidity index fails to predict outcomes in high-risk AML patients undergoing allogeneic transplantation--investigation of potential limitations of the index.
    Birninger N, Bornhäuser M, Schaich M, Ehninger G, Schetelig J.
    Biol Blood Marrow Transplant; 2011 Dec 01; 17(12):1822-32. PubMed ID: 21708108
    [Abstract] [Full Text] [Related]

  • 15. Comparison of Risk Scoring Systems in HLA-Matched Related Allogeneic Hematopoietic Stem Cell Transplantation: A Retrospective Cohort Study.
    Aladağ E, Demiroğlu H, Büyükaşık Y, Göker H.
    Turk J Haematol; 2021 Jun 01; 38(2):138-144. PubMed ID: 32539316
    [Abstract] [Full Text] [Related]

  • 16. Comparable outcomes among unmanipulated haploidentical, matched unrelated, and matched sibling donors in BU-based myeloablative hematopoietic stem cell transplantation for intermediate and adverse risk acute myeloid leukemia in complete remission: a single-center study.
    Lu Y, Zhao YL, Zhang JP, Xiong M, Cao XY, Liu DY, Sun RJ, Wei ZJ, Zhou JR, Lu DP.
    Ann Hematol; 2021 Jun 01; 100(6):1579-1591. PubMed ID: 33236196
    [Abstract] [Full Text] [Related]

  • 17. Irradiation free conditioning regimen is associated with high relapse rate in Egyptian patients with acute lymphoblastic leukemia following allogeneic hematopoietic stem cell transplantation.
    Abdelaty MM, Gawaly A, Fathy GM, Kabbash I, Taha A.
    J Egypt Natl Canc Inst; 2020 Jun 15; 32(1):28. PubMed ID: 32537680
    [Abstract] [Full Text] [Related]

  • 18. External validation and comparison of multiple prognostic scores in allogeneic hematopoietic stem cell transplantation.
    Shouval R, Fein JA, Shouval A, Danylesko I, Shem-Tov N, Zlotnik M, Yerushalmi R, Shimoni A, Nagler A.
    Blood Adv; 2019 Jun 25; 3(12):1881-1890. PubMed ID: 31221661
    [Abstract] [Full Text] [Related]

  • 19. Patient age and donor HLA matching can stratify allogeneic hematopoietic cell transplantation patients into prognostic groups.
    Garcia-Horton A, Cyriac SL, Gedde-Dahl T, Floisand Y, Remberger M, Mattsson J, Michelis FV.
    Eur J Haematol; 2022 Dec 25; 109(6):672-679. PubMed ID: 36028979
    [Abstract] [Full Text] [Related]

  • 20. Cytogenetics and comorbidity predict outcomes in older myelodysplastic syndrome patients after allogeneic stem cell transplantation using reduced intensity conditioning.
    Yucel OK, Saliba RM, Rondon G, Ahmed S, Alousi A, Bashir Q, Ciurea SO, Popat U, Khouri I, Marin D, Rezvani K, Kebriaei P, Shpall EJ, Champlin RE, Oran B.
    Cancer; 2017 Jul 15; 123(14):2661-2670. PubMed ID: 28324640
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.